Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04913064Recruiting
Open-label, single-arm trial in breast cancer, sponsored by City of Hope. Primary endpoints: Relative change in levels of circulating myeloid-derived suppressor cells (MDSCs) within the peripheral blood mononuclear (PBMC) compartment at 3 months and Relative change in immune cell composition within the peripheral blood mononuclear (PBMC) compartment at 3 months. Started Jul 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04913064.